HYRNUCO

Serial Number 99237033
686

Registration Progress

Application Filed
Jun 16, 2025
Under Examination
Approved for Publication
Dec 23, 2025
Published for Opposition
Dec 23, 2025
Registered

Attorney Assistance

Published for Opposition
Due: Jan 22, 2026 25 days

Trademark Image

HYRNUCO

Basic Information

Serial Number
99237033
Filing Date
June 16, 2025
Published for Opposition
December 23, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Dec 23, 2025
Application
Pending
Classes
005

Rights Holder

Bayer Aktiengesellschaft

25
Address
Kaiser-Wilhelm-Allee
Leverkusen 51373
DE

Ownership History

Bayer Aktiengesellschaft

Original Applicant
25
Leverkusen DE

Bayer Aktiengesellschaft

Owner at Publication
25
Leverkusen DE

Legal Representation

Attorney
Phillip Barengolts

USPTO Deadlines

Next Deadline
25 days remaining
Published for Opposition
Due Date
January 22, 2026
Extension Available
Until February 22, 2026

Application History

15 events
Date Code Type Description Documents
Dec 23, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 23, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 17, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 29, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 25, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 25, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 25, 2025 ALIE A ASSIGNED TO LIE Loading...
Nov 11, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Sep 6, 2025 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Sep 6, 2025 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Sep 6, 2025 CNSL R SUSPENSION LETTER WRITTEN Loading...
Sep 6, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 16, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 16, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 16, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of Parkinson’s disease; Pharmaceutical preparations for the treatment of and prevention of cardiovascular diseases; Pharmaceutical preparations for the treatment of and prevention of inflammation; Pharmaceutical preparations for the treatment of cancer

Classification

International Classes
005